What are the cure rates for indolent follicular lymphoma stage 2 contiguous, FLIPI 0, Ki-67 10-20%, age 48, treated with rituximab plus radiation therapy?
Great news — your profile looks quite favorable! Here's why:
- Stage 2 contiguous means the lymphoma is still localized, which responds well to radiation
- FLIPI 0 is the Show Full Answer
What are the cure rates for indolent follicular lymphoma stage 2 contiguous, FLIPI 0, Ki-67 10-20%, age 48, treated with rituximab plus radiation therapy?
Great news — your profile looks quite favorable! Here's why:
- Stage 2 contiguous means the lymphoma is still localized, which responds well to radiation
- FLIPI 0 is the lowest possible risk score — that's a really positive sign
- Ki-67 10-20% indicates slow cell growth (low proliferation)
- Age 48 puts you in the under-60 group, which carries ~95% five-year survival rates For stage 1-2 follicular lymphoma treated with radiation, studies show roughly two-thirds of patients remain disease-free after five years. The five-year overall survival rate for stage 2 is around 90%.
Adding rituximab to radiation can extend remission periods significantly compared to radiation alone, improving outcomes further.
While follicular lymphoma is generally considered not routinely curable with conventional therapy, your combination of low-risk factors gives you one of the best possible outlooks. A complete response to initial treatment also strongly predicts longer remission.
Always discuss your specific expectations with your oncologist, as individual results vary.
October 8
Join
Your Privacy Choices
